Dr Hugh Laverty takes over the reins at IHI
Dr Hugh Laverty has taken over as interim Executive Director at the Innovative Health Initiative (IHI), following the departure of Dr Pierre Meulien.
First IHI calls attract 33 proposals
We received 33 proposals in response to IHI calls 1 (18 proposals) & 2 (15 proposals). The next steps are the eligibility check, and then eligible proposals will be evaluated by independent experts.
A farewell reflection on research and innovation in the 21st century
On 15 September, Pierre Meulien’s term as IMI/IHI Executive Director drew to a close. In a final opinion piece, he reflects on the ongoing influence of IMI and IHI on the research and innovation process.
Read more
Battling drug-resistant tuberculosis: New life for old treatments
A new compound that boosts the efficacy of the tuberculosis drug ethianomide has successfully completed phase 1 clinical trials, thanks to IMI project TRIC-TB.
Reaching the desired (health) outcome
IMI project H2O has launched its first health outcomes observatories, in the Netherlands, Spain and Austria. The observatories cover cancer, diabetes, and inflammatory bowel disease.
Multiple myeloma patients may soon be able to look forward to better-targeted treatments
IMI project HARMONY is proposing a new, more accurate way of assessing the prognosis of patients with multiple myeloma, a type of cancer.
Read more